Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageOption Care Health and its subsidiaries own a variety of trademarks, licenses, and service marks, including but not limited to: “Option Care Health”, “Option Care”, “Critical Care Systems”, “Clinical Specialties”, “BioScrip”, “BioScrip Infusion Services”, “HomeChoice Partners”, “InfuScience”, “InfusionCare”, “Infusion Partners”, “Infusion Solutions”, “New England Home Therapies”, “Professional Home Care Services”, “Wilcox Home Infusion”, “Home Solutions”, “Home Solutions Infusion Therapy”, “Naven Health”, “Naven Connect”, “Restore+ by Option Care Health”, “IG Complete+”, “Care Nav+ by Option Care Health”, “BioCure”, “DP Diabetes in Pregnancy Program”, “HP Hypertension in Pregnancy Program”, “NV Nausea and Vomiting Hyperemesis Program”, “PM Prematurity Program”, “Factor Ape”, “Intramed Plus”, “Intramed Plus Infusion and Medical Center”, as well as several others.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Option Care Health, Inc. (OPCH) reported revenue of $1.35B in Q1 2026 (quarter ended March 31, 2026), up 1.3% from the same quarter a year earlier. That came with a gross margin of 19% and net income of $45M (3.4% of revenue). For the full year FY2025, revenue was $5.65B (+13% year on year) and net income $208M.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Care Facilities
Ranks #14 of 28 by Smart Score